y 27632 has been researched along with Diabetic Nephropathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AF; Chen, P; Chen, R; Chen, S; Chen, W; Liu, H; Lu, H; Xiang, H; Xiao, J; Yang, J; Yang, X; Zhao, S; Zhou, J | 1 |
| Alokam, R; Mishra, RK; Sriram, D; Yogeeswari, P | 1 |
| Huang, W; Lai, W; Li, Y; Lou, T; Peng, H; Rao, J; Tang, H; Wang, C; Ye, Z | 1 |
| Chacko, S; Chang, S; Changolkar, A; DiSanto, ME; Hypolite, JA; Wein, AJ | 1 |
| Abe, H; Fujikura, Y; Ina, K; Kitamura, H; Miyazaki, T; Tatsukawa, S | 1 |
| Lai, EY; Nordquist, L; Patzak, A; Persson, AE; Sjöquist, M | 1 |
| Bach, LA | 1 |
1 review(s) available for y 27632 and Diabetic Nephropathies
| Article | Year |
|---|---|
Potential role of Rho kinase inhibitors in combating diabetes-related complications including diabetic neuropathy--a review.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Humans; Mice; Oxidative Stress; Pyridines; Rats; rho-Associated Kinases; Sexual Dysfunction, Physiological; Signal Transduction; Vasodilator Agents | 2013 |
6 other study(ies) available for y 27632 and Diabetic Nephropathies
| Article | Year |
|---|---|
S1PR2 antagonist ameliorate high glucose-induced fission and dysfunction of mitochondria in HRGECs via regulating ROCK1.
Topics: Amides; Blood Glucose; Cells, Cultured; Diabetic Nephropathies; Endothelial Cells; Enzyme Inhibitors; Humans; Kidney Glomerulus; Mitochondria; Pyrazoles; Pyridines; rho-Associated Kinases; Signal Transduction; Sphingosine-1-Phosphate Receptors | 2019 |
The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cell Adhesion; Cell Movement; Cells, Cultured; Chemokine CCL2; Diabetic Nephropathies; Disease Models, Animal; Endothelial Cells; Glycation End Products, Advanced; Inflammation; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Mice; Mice, Mutant Strains; Protein Kinase Inhibitors; Pyridines; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Small Interfering; Signal Transduction | 2017 |
Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase beta and CPI-17.
Topics: Amides; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diuresis; Diuretics; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Intracellular Signaling Peptides and Proteins; Muscle Proteins; Muscle, Smooth; Myosins; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Rabbits; rho-Associated Kinases; Urinary Bladder | 2006 |
Contraction of tubulointerstitial fibrosis tissue in diabetic nephropathy, as demonstrated in an in vitro fibrosis model.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cells, Cultured; Collagen; Cytochalasin D; Diabetic Nephropathies; Diacetyl; Fibroblasts; Fibrosis; Kidney Tubules; Microscopy, Electron, Transmission; Models, Biological; Myosin Light Chains; Phosphorylation; Pyridines; Rats; rho-Associated Kinases; Transforming Growth Factor beta1; Wound Healing | 2007 |
Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism.
Topics: Amides; Angiotensin II; Animals; Arterioles; C-Peptide; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Norepinephrine; Potassium Chloride; Pyridines; Rho Factor; rho-Associated Kinases; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Rho kinase inhibition: a new approach for treating diabetic nephropathy?
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Diabetic Nephropathies; Humans; Mice; Protein Kinase Inhibitors; Pyridines; Rats; rho-Associated Kinases | 2008 |